CohBar, Inc. Announces Closing of First Tranche of Private Placement

Mar 29, 2018

CohBar, Inc. Announces Financing of up to US$5,000,000 in Unsecured Promissory Notes

Mar 26, 2018

CohBar, Inc. to Announce 2017 Fourth Quarter Financial Results and Host Conference Call for Shareholders on April 2, 2018

Mar 19, 2018

CohBar Announces Approval for Listing on the NASDAQ Capital Market

Dec 13, 2017

CohBar Announces the Appointment of Dr. John Amatruda to its Board

Dec 7, 2017

CohBar, Inc. Announces Third Quarter 2017 Financial Results

Nov 13, 2017

CohBar, Inc. to Announce Third Quarter 2017 Financial Results and Host Conference Call for Shareholders on November 13, 2017

Oct 26, 2017

CohBar Presents Preclinical Data on CB4209/CB4211 Program for NASH at the AASLD Liver Meeting® 2017

Oct 23, 2017

CohBar, Inc. Announces Scientific Presentation of CB4209/CB4211 Program for NASH at The AASLD Liver Meeting® 2017

Oct 4, 2017

CohBar to Present at the Rodman & Renshaw 19th Annual Global Investment Conference in New York on September 12, 2017

Sep 8, 2017